Vanguard Group Inc. Has $1.52 Billion Stake in Revvity Inc. (NYSE:RVTY)

Vanguard Group Inc. lifted its holdings in Revvity Inc. (NYSE:RVTY - Free Report) by 0.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,382,849 shares of the company's stock after purchasing an additional 92,638 shares during the period. Vanguard Group Inc. owned 11.97% of Revvity worth $1,521,705,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the business. T. Rowe Price Investment Management Inc. raised its holdings in Revvity by 16.7% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 20,761,308 shares of the company's stock worth $2,317,170,000 after acquiring an additional 2,969,326 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in Revvity by 17.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 7,631,597 shares of the company's stock worth $851,764,000 after acquiring an additional 1,151,821 shares during the period. Janus Henderson Group PLC raised its holdings in Revvity by 0.4% in the 4th quarter. Janus Henderson Group PLC now owns 6,358,952 shares of the company's stock worth $709,725,000 after acquiring an additional 23,650 shares during the period. EdgePoint Investment Group Inc. raised its holdings in Revvity by 51.1% in the 4th quarter. EdgePoint Investment Group Inc. now owns 4,058,231 shares of the company's stock worth $452,939,000 after acquiring an additional 1,372,456 shares during the period. Finally, Dimensional Fund Advisors LP raised its holdings in Revvity by 5.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,295,760 shares of the company's stock worth $144,621,000 after acquiring an additional 70,867 shares during the period. Institutional investors and hedge funds own 86.65% of the company's stock.

Analyst Ratings Changes

Several research analysts have recently issued reports on the stock. The Goldman Sachs Group dropped their price objective on shares of Revvity from $140.00 to $125.00 and set a "buy" rating on the stock in a report on Tuesday, April 29th. UBS Group upgraded shares of Revvity from a "neutral" rating to a "buy" rating and dropped their price objective for the stock from $145.00 to $115.00 in a report on Thursday, May 1st. Wells Fargo & Company dropped their price objective on shares of Revvity from $130.00 to $102.00 and set an "equal weight" rating on the stock in a report on Thursday, April 17th. JPMorgan Chase & Co. dropped their price objective on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating on the stock in a report on Tuesday, April 29th. Finally, Stifel Nicolaus dropped their price objective on shares of Revvity from $120.00 to $110.00 and set a "hold" rating on the stock in a report on Tuesday, July 29th. Five research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to data from MarketBeat.com, Revvity currently has an average rating of "Moderate Buy" and an average target price of $120.07.

Revvity Price Performance

NYSE:RVTY traded up $0.57 on Friday, reaching $90.02. The stock had a trading volume of 186,583 shares, compared to its average volume of 1,180,143. The company has a market capitalization of $10.45 billion, a P/E ratio of 38.20, a price-to-earnings-growth ratio of 2.44 and a beta of 0.91. Revvity Inc. has a 1-year low of $85.12 and a 1-year high of $129.50. The company has a quick ratio of 2.75, a current ratio of 3.33 and a debt-to-equity ratio of 0.43. The stock has a fifty day moving average price of $94.96 and a 200-day moving average price of $100.44.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings results on Monday, July 28th. The company reported $1.18 EPS for the quarter, beating analysts' consensus estimates of $1.14 by $0.04. Revvity had a net margin of 10.19% and a return on equity of 7.66%. The firm had revenue of $720.28 million for the quarter, compared to analyst estimates of $711.26 million. During the same period in the previous year, the business earned $1.22 earnings per share. The company's revenue for the quarter was up 4.1% compared to the same quarter last year. Research analysts forecast that Revvity Inc. will post 4.94 EPS for the current year.

Revvity Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 7th. Stockholders of record on Friday, October 17th will be given a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date is Friday, October 17th. Revvity's dividend payout ratio is presently 11.86%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.